TINA CHANDLER: Open Payments
NPI 1164153979 · FLORENCE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,790 in 90 payments from 22 companies in 2025. Trend: 2023 $81 · 2024 $151 · 2025 $1,790
Food & beverage: $1,790
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 17 | $257 |
| Lilly USA, LLC | 13 | $219 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $200 |
| ABBVIE INC. | 12 | $141 |
| Astellas Pharma US Inc | 2 | $138 |
| Xeris Pharmaceuticals, Inc. | 5 | $111 |
| RGH Enterprises LLC | 1 | $93 |
| Tandem Diabetes Care, Inc. | 6 | $93 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Novo Nordisk Inc | 4 | $67 |
Products named: Korlym, Kerendia, MOUNJARO, Veozah, RECORLEV, t:slim X2 Insulin Pump with Control-IQ, FARXIGA, NEXLETOL.
Industry payments across MS — which companies pay providers there.
